Warning: mysqli::__construct(): (HY000/1203): User howardkn already has more than 'max_user_connections' active connections in D:\Inetpub\vhosts\howardknight.net\al.howardknight.net\includes\artfuncs.php on line 21
Failed to connect to MySQL: (1203) User howardkn already has more than 'max_user_connections' active connections
Warning: mysqli::query(): Couldn't fetch mysqli in D:\Inetpub\vhosts\howardknight.net\al.howardknight.net\index.php on line 66
Article <_sif2nboBl6bB-iZEHCDgj7ml9A@jntp>
Deutsch   English   Français   Italiano  
<_sif2nboBl6bB-iZEHCDgj7ml9A@jntp>

View for Bookmarking (what is this?)
Look up another Usenet article 
Path: ...!news.roellig-ltd.de!open-news-network.org!weretis.net!feeder8.news.weretis.net!pasdenom.info!from-devjntp
Message-ID: <_sif2nboBl6bB-iZEHCDgj7ml9A@jntp>
JNTP-Route: nemoweb.net
JNTP-DataType: Article
Subject: Re: Vaccins muqueux =?UTF-8?Q?=3F?=
References: <HPaOO.1075990$jVLc.881746@fx15.ams4> <TtfCbnufzynlMMWyxByt71gd5fg@jntp> <mn.63ad7e8a1ac62fa2.119180@invalid.pasdepub>
Newsgroups: fr.misc.actualite.covid19
JNTP-HashClient: kT5X4BRt2c3lZ71sPe2MwdSl-mQ
JNTP-ThreadID: HPaOO.1075990$jVLc.881746@fx15.ams4
JNTP-Uri: https://nemoweb.net/?DataID=_sif2nboBl6bB-iZEHCDgj7ml9A@jntp
User-Agent: Nemo/1.0
JNTP-OriginServer: nemoweb.net
Date: Sat, 12 Oct 24 14:50:47 +0000
Organization: Nemoweb
JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:131.0) Gecko/20100101 Firefox/131.0
Injection-Info: nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2024-10-12T14:50:47Z/9058141"; posting-account="2@nemoweb.net"; mail-complaints-to="julien.arlandis@gmail.com"
JNTP-ProtocolVersion: 0.21.1
JNTP-Server: PhpNemoServer/0.94.5
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-JNTP-JsonNewsGateway: 0.96
From: Duzz' <jsuis@jreste.invalid>
Bytes: 1721
Lines: 7

Le 12/10/2024 à 15:41, Geo a écrit :
> 
> Il y a des recherches en cours depuis un certain temps en Touraine, je 
> m'en étais fait l'écho ici.

Les recherches initiées en 2021 à la Faculté de Pharmacie de Tours, 
semblent être en bonne voie :
<https://www.francebleu.fr/infos/sante-sciences/vaccin-nasal-contre-le-covid-19-developpe-a-tours-la-start-up-lovaltech-leve-7-millions-d-euros-8467365>